{"en":{"concepts":{"SEVERITY_CLASSIFICATION_NYHA_-_CLASS_II_19":"Severity classification NYHA - Class II","SEVERITY_CLASSIFICATION_NYHA_-_CLASS_I_11":"Severity classification NYHA - Class I","SEVERITY_CLASSIFICATION_NYHA_-_CLASS_II_11":"Severity classification NYHA - Class II","RHEUMATIC_HEART_DISEASE,_LESS_THAN_10_YEARS_SINCE_LAST_RHD_ATTACK_16":"Rheumatic Heart Disease, Less than 10 Years Since Last RHD Attack","RHEUMATIC_HEART_DISEASE,_IF_EITHER_QUESTION_ABOVE_IS_YES_17":"Rheumatic Heart Disease, If Either Question Above is Yes","SEVERITY_CLASSIFICATION_NYHA_-_CLASS_I_19":"Severity classification NYHA - Class I","RHEUMATIC_HEART_DISEASE,_PATIENT_HAD_VALVE_REPLACEMENT_12_DESC":"patients with resultant CHF or valve damage should be on lifelong penicillin,<br>\nSEE BELOW for dosing regimen<br>","CONGESTIVE_HEART_FAILURE,_SEVERITY_CLASSIFICATION_NYHA_19_DESC":"<b>Class I<\/b> - symptoms of HEART FAILURE only at activity levels that would limit normal individuals<br/>\n<b>Class II<\/b> - symptoms of HEART FAILURE with ordinary exertion<br/>\n<b>Class III<\/b> - symptoms of HEART FAILURE with less than ordinary exertion<br/>\n<b>Class IV<\/b> - symptoms of HEART FAILURE at rest","RHEUMATIC_HEART_DISEASE,_PATIENT_YOUNGERT_THAN_25_YEARS_15":"Rheumatic Heart Disease, Patient Youngert than 25 Years","SEVERITY_CLASSIFICATION_NYHA_-_CLASS_IV_19":"Severity classification NYHA - Class IV","RHEUMATIC_HEART_DISEASE,_DETAILS_ON_APPROPRIATE_ANTI-COAGULATION_14_DESC":"Patients with mechanical valves should be on Coumadin with goal INR 2.5-3.5","RHEUMATIC_HEART_DISEASE,_SYMPTOMS_OF_HEART_FAILURE_TODAY_10":"Rheumatic Heart Disease, Symptoms of Heart Failure Today","SEVERITY_CLASSIFICATION_NYHA_-_CLASS_IV_11":"Severity classification NYHA - Class IV","RHEUMATIC_HEART_DISEASE,_IF_EITHER_QUESTION_ABOVE_IS_YES_17_DESC":"if either question above is yes,<br>\nthen patient needs to be on penicillin until one of these requirements are met.<br> \nSee below for dosing regimen<br>","RHEUMATIC_HEART_DISEASE,_PATIENT_HAD_VALVE_REPLACEMENT_12":"Rheumatic Heart Disease, Patient Had Valve Replacement","RHEUMATIC_HEART_DISEASE,_IS_PATIENT_GETTING_Q1_MONTH_PENICILLIN_18":"Rheumatic Heart Disease, Is Patient Getting q1 Month Penicillin","RHEUMATIC_HEART_DISEASE,_SYMPTOMS_OF_HEART_FAILURE_TODAY_10_DESC":"if yes, patients with resultant CHF or valve damage should be on lifelong penicillin, SEE BELOW for dosing regimen","RHEUMATIC_HEART_DISEASE,_DETAILS_ON_APPROPRIATE_ANTI-COAGULATION_14":"Rheumatic Heart Disease, Details On Appropriate Anti-Coagulation","RHEUMATIC_HEART_DISEASE,_IS_PATIENT_GETTING_Q1_MONTH_PENICILLIN_18_DESC":"Should get PCN with doses Benzathine penicillin G<br>\nAdults above 27kg =1.2 million units IM once / 4 weeks<br>\nChildren above 27kg = 600 000 units IM once/ 4 weeks<br>","RHEUMATIC_HEART_DISEASE,_ON_APPROPRIATE_ANTI-COAGULATION_13":"Rheumatic Heart Disease, On Appropriate Anti-Coagulation","SEVERITY_CLASSIFICATION_NYHA_-_CLASS_III_19":"Severity classification NYHA - Class III","RHEUMATIC_HEART_DISEASE,_NYHA_STAGE_11":"Rheumatic Heart Disease, NYHA Stage","CONGESTIVE_HEART_FAILURE,_SEVERITY_CLASSIFICATION_NYHA_19":"Congestive Heart Failure, Severity classification NYHA","RHEUMATIC_HEART_DISEASE,_NYHA_STAGE_11_DESC":"- Class I \u2014 symptoms of HEART FAILURE only at activity levels that would limit normal individuals<br>\n- Class II \u2014 symptoms of HEART FAILURE  with ordinary exertion<br>\n- Class III \u2014 symptoms of HEART FAILURE  with less than ordinary exertion<br>\n- Class IV \u2014 symptoms of HEART FAILURE  at rest<br>","SEVERITY_CLASSIFICATION_NYHA_-_CLASS_III_11":"Severity classification NYHA - Class III"},"labels":{"LABEL_2":"This is a Test Title","BOOLEAN_NO":"No","BOOLEAN_YES":"Yes"}},"es":{"concepts":{"SEVERITY_CLASSIFICATION_NYHA_-_CLASS_II_19":"SEVERITY_CLASSIFICATION_NYHA_-_CLASS_II_19","SEVERITY_CLASSIFICATION_NYHA_-_CLASS_I_11":"SEVERITY_CLASSIFICATION_NYHA_-_CLASS_I_11","RHEUMATIC_HEART_DISEASE,_LESS_THAN_10_YEARS_SINCE_LAST_RHD_ATTACK_16":"RHEUMATIC_HEART_DISEASE,_LESS_THAN_10_YEARS_SINCE_LAST_RHD_ATTACK_16","SEVERITY_CLASSIFICATION_NYHA_-_CLASS_II_11":"SEVERITY_CLASSIFICATION_NYHA_-_CLASS_II_11","RHEUMATIC_HEART_DISEASE,_IF_EITHER_QUESTION_ABOVE_IS_YES_17":"RHEUMATIC_HEART_DISEASE,_IF_EITHER_QUESTION_ABOVE_IS_YES_17","SEVERITY_CLASSIFICATION_NYHA_-_CLASS_I_19":"SEVERITY_CLASSIFICATION_NYHA_-_CLASS_I_19","RHEUMATIC_HEART_DISEASE,_PATIENT_HAD_VALVE_REPLACEMENT_12_DESC":"RHEUMATIC_HEART_DISEASE,_PATIENT_HAD_VALVE_REPLACEMENT_12_DESC","CONGESTIVE_HEART_FAILURE,_SEVERITY_CLASSIFICATION_NYHA_19_DESC":"CONGESTIVE_HEART_FAILURE,_SEVERITY_CLASSIFICATION_NYHA_19_DESC","SEVERITY_CLASSIFICATION_NYHA_-_CLASS_IV_19":"SEVERITY_CLASSIFICATION_NYHA_-_CLASS_IV_19","RHEUMATIC_HEART_DISEASE,_PATIENT_YOUNGERT_THAN_25_YEARS_15":"RHEUMATIC_HEART_DISEASE,_PATIENT_YOUNGERT_THAN_25_YEARS_15","RHEUMATIC_HEART_DISEASE,_DETAILS_ON_APPROPRIATE_ANTI-COAGULATION_14_DESC":"RHEUMATIC_HEART_DISEASE,_DETAILS_ON_APPROPRIATE_ANTI-COAGULATION_14_DESC","SEVERITY_CLASSIFICATION_NYHA_-_CLASS_IV_11":"SEVERITY_CLASSIFICATION_NYHA_-_CLASS_IV_11","RHEUMATIC_HEART_DISEASE,_SYMPTOMS_OF_HEART_FAILURE_TODAY_10":"RHEUMATIC_HEART_DISEASE,_SYMPTOMS_OF_HEART_FAILURE_TODAY_10","RHEUMATIC_HEART_DISEASE,_IF_EITHER_QUESTION_ABOVE_IS_YES_17_DESC":"RHEUMATIC_HEART_DISEASE,_IF_EITHER_QUESTION_ABOVE_IS_YES_17_DESC","RHEUMATIC_HEART_DISEASE,_PATIENT_HAD_VALVE_REPLACEMENT_12":"RHEUMATIC_HEART_DISEASE,_PATIENT_HAD_VALVE_REPLACEMENT_12","RHEUMATIC_HEART_DISEASE,_IS_PATIENT_GETTING_Q1_MONTH_PENICILLIN_18":"RHEUMATIC_HEART_DISEASE,_IS_PATIENT_GETTING_Q1_MONTH_PENICILLIN_18","RHEUMATIC_HEART_DISEASE,_SYMPTOMS_OF_HEART_FAILURE_TODAY_10_DESC":"RHEUMATIC_HEART_DISEASE,_SYMPTOMS_OF_HEART_FAILURE_TODAY_10_DESC","RHEUMATIC_HEART_DISEASE,_DETAILS_ON_APPROPRIATE_ANTI-COAGULATION_14":"RHEUMATIC_HEART_DISEASE,_DETAILS_ON_APPROPRIATE_ANTI-COAGULATION_14","RHEUMATIC_HEART_DISEASE,_IS_PATIENT_GETTING_Q1_MONTH_PENICILLIN_18_DESC":"RHEUMATIC_HEART_DISEASE,_IS_PATIENT_GETTING_Q1_MONTH_PENICILLIN_18_DESC","RHEUMATIC_HEART_DISEASE,_ON_APPROPRIATE_ANTI-COAGULATION_13":"RHEUMATIC_HEART_DISEASE,_ON_APPROPRIATE_ANTI-COAGULATION_13","SEVERITY_CLASSIFICATION_NYHA_-_CLASS_III_19":"SEVERITY_CLASSIFICATION_NYHA_-_CLASS_III_19","RHEUMATIC_HEART_DISEASE,_NYHA_STAGE_11":"RHEUMATIC_HEART_DISEASE,_NYHA_STAGE_11","CONGESTIVE_HEART_FAILURE,_SEVERITY_CLASSIFICATION_NYHA_19":"CONGESTIVE_HEART_FAILURE,_SEVERITY_CLASSIFICATION_NYHA_19","RHEUMATIC_HEART_DISEASE,_NYHA_STAGE_11_DESC":"RHEUMATIC_HEART_DISEASE,_NYHA_STAGE_11_DESC","SEVERITY_CLASSIFICATION_NYHA_-_CLASS_III_11":"SEVERITY_CLASSIFICATION_NYHA_-_CLASS_III_11"},"labels":{"LABEL_2":"LABEL_2","BOOLEAN_NO":"BOOLEAN_NO","BOOLEAN_YES":"BOOLEAN_YES"}}}